Paratek Pharmaceuticals Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2014 | $93 M | No. 1 | $50 to $250 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Paratek Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2014).
SEC Form D · Jul 2014
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jul 2014
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Paratek Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Beverly Armstrong | Executive officer | Jul 2014 |
| Dennis Molnar | Executive officer | Jul 2014 |
| Evan Loh | Executive officer | Jul 2014 |
| Kathryn Boxmeyer | Executive officer | Jul 2014 |
| Michael Bigham | Executive officer | Jul 2014 |
| S. Ken Tanaka | Executive officer | Jul 2014 |
| Sean M. Johnston | Executive officer | Jul 2014 |
| Evan Loh | Director | Jul 2014 |
| Michael Bigham | Director | Jul 2014 |
| Richard Lim | Director | Jul 2014 |